{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:52:43Z","timestamp":1764053563446},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Communications"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1002\/hep4.1191","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T13:05:11Z","timestamp":1524834311000},"page":"625-627","source":"Crossref","is-referenced-by-count":5,"title":["Can we reliably predict response to corticosteroid treatment in severe alcoholic hepatitis?"],"prefix":"10.1097","volume":"2","author":[{"given":"Shilpa","family":"Chokshi","sequence":"first","affiliation":[{"name":"Chief Scientific Officer Institute of Hepatology,Foundation for Liver Research,London,United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"hep41191-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"e0192393","DOI":"10.1371\/journal.pone.0192393","article-title":"Survival from alcoholic hepatitis has not improved over time","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"hep41191-bib-0002-20240114","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long\u2010term outcome in severe alcoholic hepatitis","volume":"38","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"hep41191-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ajg.2009.593","article-title":"Alcoholic liver disease","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"hep41191-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short\u2010term survival in patients with severe alcoholic hepatitis: meta\u2010analysis of individual patient data","volume":"60","year":"2011","journal-title":"Gut"},{"key":"hep41191-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2010\u2010a Cochrane hepato\u2010biliary group systematic review with meta\u2010analyses and trial sequential analyses of randomized clinical trials","volume":"27","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"hep41191-bib-0006-20240114","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"hep41191-bib-0007-20240114","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection\u2010related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"hep41191-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A day\u20104 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"hep41191-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep4.1176","article-title":"Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome","volume":"2","year":"2018","journal-title":"Hepatol Commun"},{"key":"hep41191-bib-0010-20240114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","article-title":"Acetyl\u2010L\u2010carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial","volume":"26","year":"2011","journal-title":"Metab Brain Dis"},{"key":"hep41191-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/ajg.2009.719","article-title":"L\u2010carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis\u2010\u2010a randomized and controlled clinical trial","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep4.1191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.1191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.1191","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/02009842-201806000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:04:00Z","timestamp":1705248240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02009842-201806000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1191","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}